BERNAY, France and NIDWALDEN, Switzerland, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Biolog-id, a digital health solution provider focusing on value-chain optimization, and Genesis Growth Tech Acquisition ...

PARIS--(BUSINESS WIRE)--Biolog-id, a global leader in the traceability and management of sensitive health products (red blood cells, plasma, platelets and chemotherapy preparations), is announcing a ...

HAYWARD, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products, today announced the acquisition of MIDI ...

PARIS--(BUSINESS WIRE)--Biolog-id, a global leader in the traceability of sensitive therapeutic products, has just co-opted Dominik BELLOIN within the company’s board. He will sit alongside Pierre ...

Within the partnership, Curie-Cancer and Biolog-id will develop a pilot system of RFID tags suitable for use in tracking cancer chemotherapy preparations Paris and Bernay, France, June 4, 2013 - Curie ...

ATLANTA, Oct. 19, 2019 /CNW/ -- Biolog-id LLC, a world leader in connected solutions for blood products, will unveil its newest suite of technologies at the 2019 AABB Annual Meeting on October 19 ...

HAYWARD, CALIFORNIA / ACCESS Newswire / October 1, 2025 / Biolog, Inc., a trusted leader in microbial identification and testing, today announced its new Foodborne Pathogen Testing Service, out of ...

HAYWARD, CA / ACCESSWIRE / June 15, 2023 / Biolog, Inc., a leading provider of microbial polyphasic analysis, today announced the launch of the Odin™ system, an all-in-one cellular phenotyping and ...

Biolog, Inc. has announced the release of its GEN III MicroStation System. The new GEN III System is built around a single test panel that can be used to identify both Gram-negative and Gram-positive ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...